73 results
Posted on 24.03.2014
HIV 101: Tuberculosis and HIV, a Killer Combination
Today, March 24, is World TB Day. We’re examining the link between HIV and tuberculosis (TB) infections and how, by fighting these diseases together, we can create a generation free of HIV and TB!
5 WHO insights into conquering the medtech mismatch
One central theme revolved around the Second World Health Organisation’s Global Forum on Medical Devices – the WHO recognises medical devices as an investment and not a cost. However, there is a mismatch between innovation of medical devices and public health needs. 677 participants from 108 countries took their pick from 28 workshops and 4 plenary sessions. Held on November 22-24th in Geneva, the event enabled academia, international organisations, industry and NGOs to gain insight from 159 presentations, 144 posters (one of which was presented by EDMA on Lab Tests Online), and 8 films.
Hats off to policymakers for encouraging multidisciplinary wound care
Despite the overwhelming impact that wounds have on healthcare systems, many people are still unaware of the risks for developing wounds when entering a healthcare setting. In fact, 27-50 percent of acute hospital beds are likely to be occupied on any day by patients with a wound. Many of these patients will be at high risk of infection, which can result in extended hospital stays and for some, amputation. Yet, patients can be better protected against such risks by instituting evidenced based guidelines in healthcare settings that include multidisciplinary approaches to wound care treatment.
Posted on 16.10.2013
Always read the small print…on the ENVI proposal for the reprocessing of single-use medical devices
Caveat Emptor, or ‘Buyer Beware’, is a commercial rule favouring the seller, now largely extinct due to modern consumer legislation. But the European Parliament’s ENVI Committee, in its amendment on the reprocessing of single-use medical devices, has unwittingly slipped something similar back in again. Given the complex and highly technical nature of the Medical Devices Directives, I can see where busy MEPs would struggle to understand the details and consequences of this amendment, so I think it is essential that we take a moment to read the fine print.
Posted on 28.08.2013
How One Diagnostic Test Can Save Billions of Euros Per Year
In the past, percussion of the abdomen, taking temperature, or tasting sugar in urine were considered diagnostic standard of care methodologies. Today, invitro diagnostics (IVD) provide additional objective biomarkers that diagnose cancer, infections, heart attacks and many other health conditions.
Medical devices and in vitro diagnostics proposals: Information is Power
World Health Day approaching us on April 7th is meant to raise awareness on the endless host of hurdles that undermines our health and therefore, our quality of life. Public health is about making sure that the external factors that determine our health are governed by policies that have people’s well-being at the very heart of their mandate. EPHA, Europe’s leading NGO advocating for better health, is committed to that very principle.
This year marks EPHA’s 20th anniversary in advocating EU and European policy-makers on public health. Bringing today’s leaders to focus on people’s health is not an easy task. The medical devices and in vitro diagnostics files appropriately represent the juggling effort that advocating for public health usually turns out to be.
Posted on 27.02.2013
Why pressure ulcers are a patient safety issue
How many of us have elderly friends and relatives who have spent time in various healthcare settings? Were you aware of the risks associated with that care? Did you know whether your loved one was risk-assessed or properly repositioned to prevent the development of a pressure ulcer?
Posted on 14.02.2013
Improving the lives of patients in 2013
Health First Europe has always believed that by bringing together all health stakeholders, solutions for challenges in healthcare can be found that benefit all patients. In 2012, we continued in our conviction that together we could better protect patients and improve access to treatment by working with the EU institutions and other EU health stakeholders. This past year, our work on patient safety and health technology assessment (HTA) produced concrete recommendations for policymakers on how the EU can support the improvement and delivery of care for patients.
In 2013, we will not only further our work on patient safety and quality of care, but also expand our issue engagement to look beyond safety and access, to patient empowerment, health literacy and community care. Encouraging patients to be informed about their care is of great importance as health systems adapt and change to the meet the needs of an ageing population as well as shortages of healthcare professionals and tighter budgets for delivering care.
Posted on 29.11.2012
When Good Medicine Isn’t Good Enough
Advances in in vitro HIV/AIDS diagnostics, combined with the development of highly effective antiretroviral (ARV) drugs, have significantly reduced the transmission of HIV from mother to baby and greatly improved health outcomes for mothers living with HIV. Simple and inexpensive tests screen for HIV within minutes, and point of care CD4 testing enables doctors to closely monitor a patient’s immune system to prescribe an effective combination of ARVs to keep mothers healthy during and after their pregnancy and their babies HIV-free. As a result, new pediatric HIV infections have nearly halved in the last eight years and the number of deaths each year attributed to AIDS-related causes dropped 24% since the peak in 2005, to approximately 1.7 million in 2011.